We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

55 hedge funds and large institutions have $440M invested in HilleVax in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

460% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 5

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

10% more capital invested

Capital invested by funds: $400M → $440M (+$40.3M)

8.9% more ownership

Funds ownership: 70%78.9% (+8.9%)

8% more funds holding

Funds holding: 5155 (+4)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
0.88%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
10
Increased
28
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$163M
DM
2
Deerfield Management
New York
$45.1M +$738K +40,870 +2%
A
3
Abingworth
United Kingdom
$30.8M
RCM
4
RA Capital Management
Massachusetts
$29.4M
B
5
Braidwell
Connecticut
$27.1M +$29.3M +1,620,216 New
Franklin Resources
6
Franklin Resources
California
$20.8M +$10.3M +573,110 +85%
T. Rowe Price Investment Management
7
T. Rowe Price Investment Management
Maryland
$20.3M +$2.01M +111,322 +10%
BlackRock
8
BlackRock
New York
$17.2M +$4.63M +256,419 +33%
Vanguard Group
9
Vanguard Group
Pennsylvania
$11.7M +$1.29M +71,728 +11%
SG
10
StepStone Group
California
$11.3M
SB
11
Samsara BioCapital
California
$10.2M
Morgan Stanley
12
Morgan Stanley
New York
$10.1M +$9.07M +502,197 +487%
QUSVM
13
Qiming U.S. Ventures Management
Washington
$9.35M
PA
14
Perceptive Advisors
New York
$6.79M -$6.48M -358,883 -47%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.65M +$907K +50,217 +22%
State Street
16
State Street
Massachusetts
$4.36M +$744K +41,234 +19%
BI
17
BVF Inc
California
$4.16M -$2.42M -133,873 -35%
Northern Trust
18
Northern Trust
Illinois
$2.29M +$603K +33,392 +32%
Ensign Peak Advisors
19
Ensign Peak Advisors
Utah
$1.97M +$2.13M +117,746 New
FAM
20
Fred Alger Management
New York
$1.8M
Charles Schwab
21
Charles Schwab
California
$1.72M +$204K +11,278 +12%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$835K +$152K +8,411 +20%
Swiss National Bank
23
Swiss National Bank
Switzerland
$472K +$509K +28,200 New
N
24
Nuveen
North Carolina
$400K +$99.9K +5,533 +30%
AA
25
ALPS Advisors
Colorado
$378K +$77.9K +4,317 +24%

HLVX Hedge Fund Activity: Q4 2022 in Review

55 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q4 2022, worth a combined $440M — up 10% from $400M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new HLVX positions and 6 closed out — a net gain of 4 holders — while 28 added to existing stakes and 5 trimmed.

The largest buyer was Franklin Resources, adding an estimated $10.3M. The largest seller was Perceptive Advisors, cutting an estimated $6.48M.

  • 55 institutional investors held HilleVax (HLVX) as of Q4 2022, up from 51 in Q3 2022.
  • Funds reported $440M of HilleVax stock for Q4 2022, up 10% quarter-over-quarter.
  • 10 funds opened new HilleVax positions in Q4 2022 and 6 closed out, a net change of +4 holders.
  • The largest HilleVax buyer in Q4 2022 was Franklin Resources, an estimated $10.3M added.
  • The largest HilleVax seller in Q4 2022 was Perceptive Advisors, an estimated $6.48M sold.

Based on aggregated 13F filings for Q4 2022.